🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
This Phase 1/2, open-label, biomarker-guided platform study evaluates the s...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07510828
Treatments Being Tested
This study evaluates the safety, tolerability, and preliminary anti-tumor a...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07589543
Treatments Being Tested
This Phase 1/2 study evaluates the safety, feasibility, and preliminary ant...
Status
Recruiting
Location
District One Hospital
Start Date
2026-02-01
Trial ID
NCT07410494
Treatments Being Tested
This example Phase 1/2 protocol evaluates allogeneic EGFR/HER2 dual-target ...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07617805
Treatments Being Tested
This example study evaluates the safety, feasibility, cellular kinetics, an...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07622940
Treatments Being Tested